Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
Lee Hatter, Pepa Bruce, Mark Holliday, Augustus J. Anderson, Irene Braithwaite, Andrew Corin, Allie Eathorne, Arthur Grimes, Matire Harwood, Thomas Hills, Ciléin Kearns, Kyley Kerse, John Martindale, Barney Montgomery, Lynn Riggs, Davitt Sheahan, Nick Shortt, Katja Zazulia, Mark Weatherall, David McNamara, Catherine A. Byrnes, Andrew Bush, Stuart R. Dalziel, Richard Beasley

ERJ Open Research Oct 2021, 7 (4) 00271-2021; DOI: 10.1183/23120541.00271-2021
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough
Rayid Abdulqawi, Imran Satia, Kimberley J. Holt, Rachel Dockry, Shilpi Sen, Jaclyn A. Smith

ERJ Open Research Jul 2021, 7 (3) 00447-2021; DOI: 10.1183/23120541.00447-2021
Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy
Maria Di Cicco, Ester Del Tufo, Eva Parolo, Mariacristina Menconi, Sayla Bernasconi, Chiara Romei, Alessandro Di Gangi, Beatrice Masini, Diego Peroni, Gabriella Casazza

ERJ Open Research Jul 2021, 7 (3) 00407-2021; DOI: 10.1183/23120541.00407-2021
Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
Suqiao Yang, Yuanhua Yang, Yixiao Zhang, Tuguang Kuang, Juanni Gong, Jifeng Li, Yidan Li, Jianfeng Wang, Xiaojuan Guo, Ran Miao

ERJ Open Research Jul 2021, 7 (3) 00082-2021; DOI: 10.1183/23120541.00082-2021
Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study
Adrian Gillissen, Andrea Marseille, Dirk Skowasch, John Ritz, Muriel Mattiucci-Guehlke, Stefan Pabst, Timm Greulich, Rembert Koczulla

ERJ Open Research Jul 2021, 7 (3) 00004-2021; DOI: 10.1183/23120541.00004-2021
Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma
Katrine Prætorius, Daniel P. Henriksen, Johannes M. Schmid, Pernille Printzlau, Lars Pedersen, Hanne Madsen, Ehm A. Andersson, Louise Klokker Madsen, Bo L. Chawes

ERJ Open Research Jul 2021, 7 (3) 00306-2021; DOI: 10.1183/23120541.00306-2021
Disease activity in COPD: time to make imaging biomarkers a PET project?
Stephen Milne, Rachel L. Eddy, Don D. Sin

ERJ Open Research Jul 2021, 7 (3) 00445-2021; DOI: 10.1183/23120541.00445-2021
Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer
Maysa Alhawmdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson, Mojgan Najafzadeh

ERJ Open Research Jul 2021, 7 (3) 00555-2020; DOI: 10.1183/23120541.00555-2020
Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis
Osamu Nishiyama, Kensuke Kataoka, Masahiko Ando, Shinichi Arizono, Akira Morino, Koichi Nishimura, Tomoya Ogawa, Akira Shiraki, Fumiko Watanabe, Ryo Kozu, Takashi Ogura, Yasuhiro Kondoh

ERJ Open Research Jul 2021, 7 (3) 00321-2021; DOI: 10.1183/23120541.00321-2021
Biologicals in childhood severe asthma: the European PERMEABLE survey on the status quo
Elisangela Santos-Valente, Heike Buntrock-Döpke, Rola Abou Taam, Stefania Arasi, Arzu Bakirtas, Jaime Lozano Blasco, Klaus Bønnelykke, Mihai Craiu, Renato Cutrera, Antoine Deschildre, Basil Elnazir, Louise Fleming, Urs Frey, Monika Gappa, Antonio Nieto García, Kirsten Skamstrup Hansen, Laurence Hanssens, Karina Jahnz-Rozyk, Milos Jesenak, Sebastian Kerzel, Matthias V. Kopp, Gerard H. Koppelman, Uros Krivec, Kenneth A. MacLeod, Mika Mäkelä, Erik Melén, Györgyi Mezei, Alexander Moeller, Andre Moreira, Petr Pohunek, Predrag Minić, Niels W.P. Rutjes, Patrick Sammut, Nicolaus Schwerk, Zsolt Szépfalusi, Mirjana Turkalj, Iren Tzotcheva, Alexandru Ulmeanu, Stijn Verhulst, Paraskevi Xepapadaki, Jakob Niggel, Susanne Vijverberg, Anke H. Maitland-van der Zee, Uroš Potočnik, Susanne M. Reinartz, Cornelis M. van Drunen, Michael Kabesch

ERJ Open Research Jul 2021, 7 (3) 00143-2021; DOI: 10.1183/23120541.00143-2021

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us